LA MESA, Calif., March 28, 2006 (PRIMEZONE) -- Nicodrops, Inc. (Pink Sheets:NCDP), developer of the drug-free, non-nicotine smoking alternative, herbal dietary supplement, announced that Nicodrops was an exhibitor at the Natural Products Expo West trade show in Anaheim, California and was represented by a sales team consisting of Chris Calpito, CEO, Joel Appel, VP of Sales, and recently hired consultant Chuck Brockett of BTI International. The show, which ran from March 24th to March 26th, included over 2,500 manufacturers and was attended by more than 15,000 retail buyers and distributors. The Nicodrops booth received many compliments, and interest in the product from potential customers was very high. Several orders for Nicodrops were written at the show and there will be immediate follow-up on many additional sales leads.
The show was also attended by "manufacturers' reps" (companies which solicit orders on behalf of manufacturers) who specialize in obtaining distribution of products in health food stores, convenience stores, warehouse clubs, hotel gift shops and airport gift shops both in the U.S. and internationally. The sales team met with several of these reps and preliminary agreements were reached whereby they would attempt to secure distribution for Nicodrops in these new classes of trade.
Chris Calpito, CEO, stated, "I was very encouraged by the response to our product at the show and believe it represents another step forward in our strategy of expanding the distribution of Nicodrops into new markets."
About Nicodrops:
Nicodrops, Inc., La Mesa, Calif., developed a drug-free, non-nicotine product which helps reduce the stress associated with not smoking, using all natural herbs (i). For more information go to http://www.nicodrops.com or call 1-866-844-5383.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. The words "believe," "expect," "anticipate," and "project," and similar expressions identify forward-looking statements, which speak only as of the date the statement was made. Such statements may include, but not be limited to, projections of revenues, income or loss, expenses, plans, and assumptions relating to the foregoing. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future results could differ materially from those described in forward-looking statements.
(i) These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases.